Gold
Entrée Health
Entrée Health tries hard to distinguish itself by its tenacity, impact and the heart it pours into its work, striving to fill every experience with humanity and grace.
Entrée Health offers strategic and tactical market access solutions designed to help manufacturers effectively and efficiently get their products into the hands of patients, ensure coverage and affordability and eliminate barriers to access.
A fully dedicated market access agency, it likes to brag about its staff, a unique collection of nerds, creatives, operations and client relationship gurus. Each business unit is led by creative and client services leads, rejecting the traditional tension between these disciplines — with joint responsibility for creative excellence, business growth and staff development.
Its offerings include Valuate Health Consultancy, with industry-leading analytics to optimize value strategy and commercialization, and Archbow Consulting, which helps pharma and biotech companies reach their commercial goals with strategic and tactical approaches to distribution, pharmacy and patient access.
Last year, the agency introduced Access Next, a pull-through product it believes is the market access industry’s first real innovation in pull-through in 15 years. Access Next surfaces the recent and important sales and behavioral data by physicians, then integrates it with familiar platforms to deliver custom comms. It also debuted Cognuity, a data-driven, self-learning platform that enables intelligent interactions.
The firm also added many wins, including assignments from AbbVie, Amgen, AstraZeneca, Gilead, Merck, Pfizer and ViiV.
Silver
Mosaic Group
While 2022 brought client consolidation, an economic downturn and a storm of uncertainty to the pharma industry, Mosaic continued to thrive. The business grew 15%, following 70% growth in 2021, and added 11 new major account wins from five clients. Mosaic led the launch of a new product for rare kidney disease, the third-to-market COVID-19 vaccine and seven indication launches for AbbVie.
